Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 3, Issue 108, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.3002785
Keywords
-
Categories
Funding
- CIC of the CRI
- Wallace Coulter Foundation
Ask authors/readers for more resources
Assays that measure a patient's immune response play an increasingly important role in the development of immunotherapies. The inherent complexity of these assays and independent protocol development between laboratories result in high data variability and poor reproducibility. Quality control through harmonization-based on integration of laboratory-specific protocols with standard operating procedures and assay performance benchmarks-is one way to overcome these limitations. Harmonization guidelines can be widely implemented to address assay performance variables. This process enables objective interpretation and comparison of data across clinical trial sites and also facilitates the identification of relevant immune biomarkers, guiding the development of new therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available